The landscape of dementia analysis has advanced substantially with the appearance of advanced biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based checks that may detect Alzheimer's pathology decades prior to indications emerge. Although these technological advancements represent impressive development in being familiar with n